Widely used:Recently Viewed
Clear AllQuality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$4 Mln
P/E Ratio
--
P/B Ratio
0.23
Industry P/E
--
Debt to Equity
0
ROE
-0.53 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
-2.87
CFO
$-118.16 Mln
EBITDA
$-128.19 Mln
Net Profit
$-126.82 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Check-Cap - ADR (CHEK)
| -34.54 | -26.28 | -47.32 | -71.33 | -55.74 | -42.81 | -52.45 |
|
BSE Sensex
| 1.72 | 3.50 | 4.95 | 8.90 | 11.18 | 21.04 | 11.14 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Check-Cap - ADR (CHEK)
| -5.45 | -83.70 | 46.74 | -73.26 | -20.00 | -79.22 | -62.99 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 | 11.73 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 2.21 | 27.72 | -- | -79.46 | |
| 1.41 | 143.75 | -- | -23.63 | |
| 1.88 | 81.30 | -- | -103.34 | |
| 10.00 | 445.73 | -- | 342.83 |
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural... abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel. Address: Check-Cap Building, Isfiya, Israel, 3009000 Read more
CEO & Director
Mr. Alex Ovadia
CEO & Director
Mr. Alex Ovadia
Headquarters
Isfiya
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Check-Cap Ltd - ADR (CHEK) stood at $ 50 Mln as on 31-Mar-24
The share price of Check-Cap Ltd - ADR (CHEK) is $0.65 (NASDAQ) as of 22-Apr-2025 11:42 EDT. Check-Cap Ltd - ADR (CHEK) has given a return of -55.74% in the last 3 years.
Check-Cap Ltd - ADR (CHEK) has a market capitalisation of $ 4 Mln as on 21-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Check-Cap Ltd - ADR (CHEK) is 0.23 times as on 21-Apr-2025, a 91% discount to its peers’ median range of 2.50 times.
Since, TTM earnings of Check-Cap Ltd - ADR (CHEK) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Check-Cap Ltd - ADR (CHEK) and enter the required number of quantities and click on buy to purchase the shares of Check-Cap Ltd - ADR (CHEK).
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel. Address: Check-Cap Building, Isfiya, Israel, 3009000
The CEO & director of Mr. Alex Ovadia. is Check-Cap Ltd - ADR (CHEK), and CFO & Sr. VP is Mr. Alex Ovadia.
There is no promoter pledging in Check-Cap Ltd - ADR (CHEK).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
48
|
|
|
15
|
|
|
8
|
|
|
5
|
| Check-Cap Ltd. - ADR (CHEK) | Ratios |
|---|---|
|
Return on equity(%)
|
-65.71
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Check-Cap Ltd - ADR (CHEK) was $-7 Mln.
$0.00
(
